Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemia
- 1 September 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 27 (5) , 397-400
- https://doi.org/10.1007/bf00688865
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrineCancer Chemotherapy and Pharmacology, 1989
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Comparison of the Pharmacokinetics of AMSA and AMSA-Lactate in Patients with Acute Nonlymphoblastic LeukemiaTherapeutic Drug Monitoring, 1987
- The Clinical Pharmacology of Etoposide and TeniposideClinical Pharmacokinetics, 1987
- The binding of amsacrine to human plasma proteinsJournal of Pharmacy and Pharmacology, 1986
- High-Performance Liquid Chromatographic Analysis of the Semisynthetic Epipodophyllotoxins Teniposide and Etoposide Using Electrochemical DetectionJournal of Pharmaceutical Sciences, 1984
- ROLE OF TOPOISOMERASE-II IN MEDIATING EPIPODOPHYLLOTOXIN-INDUCED DNA CLEAVAGE1984
- High-performance liquid chromatographic method for the determination of 4′-(9-acridinylamino)methanesulfon-m-anisidide in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- PHASE I-II STUDY OF M-AMSA ADMINISTERED AS A CONTINUOUS INFUSION1982
- Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule.1979